Workshop 4: Preventing Falls through Medication Vigilance

Size: px
Start display at page:

Download "Workshop 4: Preventing Falls through Medication Vigilance"

Transcription

1 Workshop 4: Preventing Falls through Medication Vigilance Nancy L. Losben, R.Ph., CCP, FASCP, CG Chief Quality Officer Omnicare, Inc. & Diane C. Vaughn, RN, C-DONA/LTC, LNHA VP, Clinical Services Benedictine Health System Goals Describe how medication risk awareness is involved with the HATCh model Identify the effect falls have on the elderly Describe common pharmacologic issues and meds that contribute to falls 1

2 Holistic Approach to Transformation Change Model (HATCh) Six Competency Domains Care Practices Competency 1.1Demostrate an Understanding of risks that lead to falls 1. Identify Medications that May Contribute to Falls and Fall Risk 2

3 Competency-Based Education (CBE) a cluster of related knowledge, skills, and attitudes that affects a major part of one s job (a role or responsibility), that correlates with performance on the job, that can be measured against wellaccepted standards, and that can be improved via training and development. Training focuses on learning desired outcomes Design makes statements of observable and measurable behavior Staff must have the necessary knowledge, skill and attitude to attain the highest level of performance. Competency Based Education 3

4 Background 2 nd most common adverse event Occur in 30-60% of the older adults / year 10-20% result in serious injury, hospitalizations, and / or death 10% of ER and 6% of hospitalizations >65 YO Falls are the leading cause of injuries in older adults Medications 32,000 Seniors Suffer Hip Fractures Caused By Medications 20% Will Die Within 5 Years On average, individuals 65 to 69 years old take nearly 14 prescriptions per year, individuals aged 80 to 84 take an average of 18 prescriptions per year 4 medications is considered a falls risk 4

5 Falls Risk Factors Weakness Unsteadiness Confused State Sleep Quality Medications Medications and Falls Common Pharmacologic Mechanisms: Orthostatic hypotension Dizziness Decreased postural reflexes Extrapyramidal symptoms Myorelaxant effects Visual impairment Impaired cognition / CNS effects 5

6 AHCA/NCAL Webinars Preventing Falls through Medication Vigilance Nancy L. Losben, R.Ph., CCP, FASCP, CG Chief Quality Officer Omnicare, Inc. Objectives To recognize the medication regimen as a risk for safety and falls. To identify the timeframe when a resident is at his/her highest risk to fall after a change in in the medication regimen. To enhance and coordinate safety and quality improvement activities. 12 6

7 Centers for Disease Control and Prevention 5% of adults 65 and older live in nursing homes but 20% of deaths from falls (1,800 yearly) Up to 20% of falls cause serious injuries Reasons for falls in LTF facilities: frailty, chronic conditions, gait disturbances, memory problems, ADL decline, medications Fall risk is significantly elevated during the 3 days following any drug that affects the central nervous system 13 Any one of these medication related problems (MRP) can increase the risk for falling Drowsiness Dizziness Low blood pressure Low heart rate Parkinson s effect Ataxia/gait disturbance Vision disturbance Low blood sugar Urinary urgency 14 7

8 Adverse Consequences Some adverse consequences occur quickly or abruptly, while others are more insidious and develop over time. Adverse consequences may become evident at any time after the medication is initiated, e.g., when there is a change in dose or after another medication has been added. When reviewing medications used for a resident, it is important to be aware of the medication s recognized safety profile, tolerability, dosing, and potential medication interactions. Although a resident may have an unanticipated reaction to a medication that is not always preventable, many ADRs can be anticipated, minimized, or prevented. In theory, any medication, or a lack of one, can be the underlying cause of a fall. But do you know which medications are most likely to increase the risk of falling? 16 8

9 Medication Categories Recognized as Risks for Falling Opioid analgesics Anticonvulsants Antidepressants Anti-Parkinson s Anxiolytics Antipsychotics Antihistamines Antiarrhythmic Appetite stimulant Barbiturates Diuretics Hypoglycemics; insulin Medications to treat continence 17 Medications associated with Injury with a Fall Anticoagulants Anti-seizure medications Chemotherapy Laxatives Psychopharmacologics Sedatives/hypnotics 9

10 Diuretics Hypotension Urinary urgency Incontinence Dehydration Electrolyte imbalance Temporal effect Onset Peak 19 Cardiovascular Drugs Hypotension Low heart rate Lethargy Delirium Syncope, dizziness Bleeding Immediate release Vs. Sustained release 20 10

11 Antipsychotics Routine, seldom PRN Lowest Possible Dose Recent Dose Increase or Reduction Extrapyramidal Side Effects Blurred Vision Lethargy Somnolescence Is it efficacious? 21 Anxiolytics Routine vs. PRN orders Short acting benzodiazepines preferred Lowest possible dose Recent dose increase or reduction Lethargy Efficacy 22 11

12 Hypnotics Routine Vs. PRN Short Acting Benzodiazepines or newer nonbenzodiazepines Given while in bed Used no more than 10 consecutive days or manufacturer s suggested direction Morning functionality/hangovers Falls out of bed 23 Antidepressants Tricyclic's Highly anticholinergic Blurred Vision Confusion Changes in heart rate Restlessness, sleeplessness Drug Interactions SSRI s and SSNRI s have a better safety profile 24 12

13 Muscle Relaxants and Antiparkinson Drugs Muscle weakness Central nervous system effects Behavioral symptoms Temporal relationship to administration and ADL performance 25 Laxatives Cathartics/bowel urgency Electrolyte imbalance Tolerance, Impaction Toileting plan Opioid therapy and anticholinergics can cause constipation 26 13

14 Pain Medications Opioids Risk vs. Benefit Drowsiness/dizziness Vs. Relief Constipation Vs. Mobility Non-steroidal anti-inflammatory drugs GI effects Confusion, other CNS effects 27 Anticholinergic Medications Medications that could affect function, level of consciousness, gait, balance, visual acuity, or cognitive ability, Causing symptoms such as dry mouth, blurred vision, tachycardia, urinary retention, constipation, confusion, delirium, excitability, memory loss, unsteadiness, dizziness, or hallucinations. 14

15 Anticholinergic Effect Blind as a bat. Mad as a hatter, red as a beet, hot as Hades, dry as a bone, the bowel and bladder lose their tone, and the heart runs alone." 29 Anticholinergic Drugs often antihistamines, antidepressants, over active bladder medications examples Generic Brand Name Generic Brand Name Amantadine Symmetrel Hydroxyzine Vistaril Clozapine Clozaril Meclizine Antivert Cyclobenzaprine Flexeril Ranitidine Zantac Diphenoxylate/ atropine Lomotil Olanzapine Zyprexa Diphenhydramine Benadryl Oxybutynin Oxytrol Desipramine Norpraminl Paxoxetine Paxil Furosemide Lasix Tolterodine Detrol 15

16 Syncope Diuretics Calcium channel blockers ACE inhibitors Nitrates Antipsychotics Antihistamines Anti-Parkinson's medications Opioids Alcohol Managing Medication- Related Syncope The first 72 hours following modification of any of these medications is the timeframe of highest risk to fall Alert care staff to any affected resident with a change in their medication regimen to a higher risk of fall Focus on residents who are usually independent in ADL s Remind residents to rise slowly Temporarily use a gait belt Monitor blood pressure daily Observe and document the resident s response to the medication Report findings to the physician and and pharmacist 16

17 Sometimes, adding a medication to a resident s medication regimen can help to reduce falls and minimize injuries. Unmanaged Pain as a Risk for Falls Residents in pain will likely avoid painful stimulus by sitting and lying down Increases the risk of fall as a result of deconditioning Residents in pain will also attempt to change position to find a more comfortable state 17

18 Managing Pain Classification Acute Recent onset Chronic nociceptive- somatic, visceral neuropathic mixed/unspecified psychologically mediated Chronic Malignant Chronic Non-malignant Identify Underlying Conditions that May Cause Pain PAIN Heart Angina Neurological Heart Attack Herpes Zoster Thrombosis Spinal and nerve injury Peripheral vascular disease Dental Pain Skin Wounds Ulcers Incisions infections Neurological Diabetic Neuropathy Herpes Zoster Spinal and nerve injury 36 Musculoskeletal Arthritis Fracture Osteoporosis Back problems Amputation Cancer GI Pain WALA 18

19 Treating Pain to Achieve Mobility and Strength Principles for Analgesics Choice of Drug Appropriate for patient's type of pain What has worked in the past Appropriate for patient s severity of pain At level appropriate to assessed pain Use combinations of drugs Not necessarily combined drugs Ongoing evaluation Benefit Risks 38 WALA 19

20 Principles for Analgesics Administration Adequate doses Titrate to individual needs Patient response Drug itself Onset Peak effect Duration Around the clock 39 WALA Principles for Analgesics Administration Address breakthrough pain Same drug if possible Monitor benefit Consider risk for ADRs Address early Advise resident Oral route whenever possible Or other non-invasive Review and evaluate 40 WALA 20

21 Vitamin D Can reduce falls by reducing osteoporosis and preventing sarcopenia (loss of muscle mass) Benefits of Vitamin D are distinct from its effect on bone. Controversial Evaluating Falls at Care Conference Previous fall, initial fall Circumstances, use incident report with Vital Signs for analysis Medication Regimen as a risk 4 or more drugs, new drug Drug therapy class Temporal relationship to fall Chemical restraints Review behavior monitoring sheets Blood sugars, blood pressures, pulses Lab tests: glucose, electrolytes, hydration, hemoglobin/hematocrit 42 21

22 Reducing the Risk Approaches Eliminate unnecessary drugs Find lowest effective doses of medications through dose reduction Monitor efficacy and resident responses to medications Monitor labs 43 Evaluation of Falls at Quality Improvement Meetings Interdisciplinary- Don t forget to include: Rehab Services Dietitian Pharmacist Environmental Services Bring List of those who have Fallen Crosswalk to Psychotropic Drug list Crosswalk to changes in condition Crosswalk to those who experienced infection Crosswalk it to those who had changes in their medication regimen 44 22

23 Evaluation of Falls with Injury Crosswalk it to residents on anticoagulants Crosswalk it to residents with a diagnosis of osteoporosis Crosswalk it to residents treated for seizures Crosswalk it to residents who use hypnotics Crosswalk it to resident with a history of impaction and/or laxative use Summary A fall may be the result of an adverse drug reaction of any medication or combination of medications A resident is most likely to fall within the first 3 days of a change in the medication regimen Planning to minimize falls during QA/PI meetings requires comparison of data from multiple sources

24 Join us for Live Chat Tuesday, September 23 ahcancal ahcancal 24

Falls most commonly seen in RACFs are due to tripping, slipping and stumbling (21.6%). Falling down stairs is relatively uncommon in

Falls most commonly seen in RACFs are due to tripping, slipping and stumbling (21.6%). Falling down stairs is relatively uncommon in This Presentation Medications and Falls Dr Peter Tenni M Pharm (Curtin), PhD (UTAS) AACPA Director, CPS A fall is an event which results in a person coming to rest inadvertently on the ground or floor

More information

Geriatric Pharmacology

Geriatric Pharmacology Geriatric Pharmacology Janice Scheufler R.Ph.,PharmD, FASCP Clinical Pharmacist Hospice of the Western Reserve Objectives List three risk factors for adverse drug events in the elderly Discuss two physiological

More information

Medications Contributing to Falls. Kate Niemann, PharmD BCGP AuBurn Pharmacy

Medications Contributing to Falls. Kate Niemann, PharmD BCGP AuBurn Pharmacy Medications Contributing to Falls Kate Niemann, PharmD BCGP AuBurn Pharmacy Why Are Falls Important? Leading cause of injury in elders Costs to the system (CDC, 2008) ER Visits: 2.2 million $28.2 billion

More information

Geri-PARDY! (2015 Beers Criteria) Pharmacology Edition

Geri-PARDY! (2015 Beers Criteria) Pharmacology Edition Geri-PARDY! Pharmacology Edition (2015 Beers Criteria) Aurelio Muyot, MD, AGSF, FACP Assistant Professor College of Osteopathic Medicine Touro University Nevada Objectives Review the 2015 Beers Criteria

More information

Medications and the I/DD Population

Medications and the I/DD Population Medications and the I/DD Population A Supplemental Document to Session 4 in Webinar Series ADR Symptoms that Mimic Age Related/Associated Changes and Diseases Biological Changes Impaired senses Cardiovascular

More information

COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK

COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK Robert L Alesiani, PharmD, CGP Chief Pharmacotherapy Officer CareKinesis, Inc. (a Tabula Rasa Healthcare Company) 2 3 4 5 Pharmacogenomics

More information

Fall Prevention in Hospice (A pharmacologic and nonpharmacologic approach)

Fall Prevention in Hospice (A pharmacologic and nonpharmacologic approach) Fall Prevention in Hospice (A pharmacologic and nonpharmacologic approach) Chinenye Emereole, Pharm.D. Clinical Pharmacist Hospice Pharmacy Solutions Objectives Assess and identify hospice patients who

More information

Introductory Clinical Pharmacology Chapter 32 Antiparkinsonism Drugs

Introductory Clinical Pharmacology Chapter 32 Antiparkinsonism Drugs Introductory Clinical Pharmacology Chapter 32 Antiparkinsonism Drugs Dopaminergic Drugs: Actions Symptoms of parkinsonism are caused by depletion of dopamine in CNS Amantadine: makes more of dopamine available

More information

Updates to CMS SOM rules on Psychosocial Issues, Deficiency Categorization, and Psychotropic Medication Use

Updates to CMS SOM rules on Psychosocial Issues, Deficiency Categorization, and Psychotropic Medication Use Updates to CMS SOM rules on Psychosocial Issues, Deficiency Categorization, and Psychotropic Medication Use Stephen Eide R. Ph Oni Kinberg LCSW, MSSW Updates to the SOM On March 25, 2016 CMS sent out updates

More information

Managing falls in the elderly: real world approach DR PRISCILLA NG

Managing falls in the elderly: real world approach DR PRISCILLA NG Managing falls in the elderly: real world approach DR PRISCILLA NG A fall is defined as an event which results in a person coming to rest inadvertently on the ground or floor or other lower level. FALL:

More information

Dementia and Fall Geriatric Interprofessional Training. Wael Hamade, MD, FAAFP

Dementia and Fall Geriatric Interprofessional Training. Wael Hamade, MD, FAAFP Dementia and Fall Geriatric Interprofessional Training Wael Hamade, MD, FAAFP Prevalence of Dementia Age range 65-74 5% % affected 75-84 15-25% 85 and older 36-50% 5.4 Million American have AD Dementia

More information

Norpramin (desipramine)

Norpramin (desipramine) Generic name: Desipramine Available strengths: 10 mg, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg tablets Available in generic: Yes Drug class: Tricyclic antidepressant General Information Norpramin (desipramine)

More information

Black holes taped on floor Redirection Music and activities Yellow straps across the door Remind other residents to use call bell when she comes in

Black holes taped on floor Redirection Music and activities Yellow straps across the door Remind other residents to use call bell when she comes in Intrusive Wandering Case study........................................... A 97 year old woman with dementia lives in a mixed 23 bed LTC unit. She is independently mobile in her wheelchair and goes in and

More information

Primary Care Approach for Evaluating the Risk of Falls with Elderly Patients. Danielle Hansen, DO, MS (Med Ed), MHSA

Primary Care Approach for Evaluating the Risk of Falls with Elderly Patients. Danielle Hansen, DO, MS (Med Ed), MHSA Primary Care Approach for Evaluating the Risk of Falls with Elderly Patients Danielle Hansen, DO, MS (Med Ed), MHSA Clinical Assistant Professor, LECOM Associate Director, LECOM Institute for Successful

More information

Presenter. Dr. Ronald Lucchino

Presenter. Dr. Ronald Lucchino Adverse Drug Reactions in Adults with Down Syndrome Presenter Dr. Ronald Lucchino rvluc@comcast.net PURPOSE To increase staff awareness that older adults with DD may have higher levels of medication in

More information

Management of Delirium in Hospice Patients

Management of Delirium in Hospice Patients Presentation Objectives Management of Delirium in Hospice Patients Lynn Williams, BSPharm Clinical Pharmacist Hospice Pharmacy Solutions Identify the clinical features of delirium Understand the underlying

More information

Objectives. Epidemiology. Diagnosis 3/27/2013. Identify positive and negative symptoms used for diagnosis of schizophrenia

Objectives. Epidemiology. Diagnosis 3/27/2013. Identify positive and negative symptoms used for diagnosis of schizophrenia Objectives Identify positive and negative symptoms used for diagnosis of schizophrenia Mohamed Sallout, Pharm D. Pharmacist Resident St. Luke s Magic Valley Regional Medical Center List medications used

More information

BEERs For the Elderly

BEERs For the Elderly BEERs For the Elderly February 2008 Presented by:carla Ambrosini Seniors First Clinic Pharmacist 12/05/2008 1 Objectives To highlight the overall health care impact of drug related adverse reactions and

More information

Application for Endorsement of CQI (Clinical Audit) Activities for MOPS Credits Allocation

Application for Endorsement of CQI (Clinical Audit) Activities for MOPS Credits Allocation Application for Endorsement of CQI (Clinical Audit) Activities for MOPS Credits Allocation Below is the form you need to fill out. NAME Dianne Vicary Health Hawke s Bay DATE JUNE 2012 TITLE OF ACTIVITY

More information

Delirium. Assessment and Management

Delirium. Assessment and Management Delirium Assessment and Management Goals and Objectives Participants will: 1. be able to recognize and diagnose the syndrome of delirium. 2. understand the causes of delirium. 3. become knowledgeable about

More information

Every year, a third of Americans over age 65

Every year, a third of Americans over age 65 Falls and mobility problems are not just part of getting old! Every year, a third of Americans over age 65 living in the community suffer a fall, and 50% over the age of 80 fall at least once per year.

More information

POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE

POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE Jeannie Kim Lee, PharmD, BCPS, CGP Clinical Pharmacy Director College of Pharmacy The University of Arizona Learning Objectives: State the risks of

More information

Raritan Bay Medical Center

Raritan Bay Medical Center Raritan Bay Medical Center For any question regarding Med of the Month. You may contact : Sherr Ann Arabit MSN, RN-BC, CCRN Professional Development Department Ext 4196 1 Professional Development Presents

More information

Pamelor (nortriptyline)

Pamelor (nortriptyline) Generic name: Nortriptyline Available strengths: 10 mg, 25 mg, 50 mg, 75 mg capsules; 10 mg/5 ml oral solution Available in generic: Yes Drug class: Tricyclic antidepressant General Information Pamelor

More information

STOPP START Toolkit Supporting Medication Review in the Older Person

STOPP START Toolkit Supporting Medication Review in the Older Person STOPP START Toolkit Supporting Medication Review in the Older Person STOPP: Screening Tool of Older People s potentially inappropriate Prescriptions START: Screening Tool to Alert doctors to Right (appropriate,

More information

STOPP and START criteria October 2011

STOPP and START criteria October 2011 # START and STOPP are newer criteria to identify potentially inappropriate medications in elderly, including drug drug and drug disease interactions, drugs which increase risk of falls and drugs which

More information

Prevention of Medication-Related Falls Through Appropriate Medication Use. Clay Sprouse, MEd., CPhT Piedmont Technical College

Prevention of Medication-Related Falls Through Appropriate Medication Use. Clay Sprouse, MEd., CPhT Piedmont Technical College Prevention of Medication-Related Falls Through Appropriate Medication Use Clay Sprouse, MEd., CPhT Piedmont Technical College Disclosure I have no relevant financial or nonfinancial relationships to disclose

More information

Psychoactive Medications. Alya Reeve, MD Carla Fedor, RN, CDDN Continuum of Care Project

Psychoactive Medications. Alya Reeve, MD Carla Fedor, RN, CDDN Continuum of Care Project Psychoactive Medications Alya Reeve, MD Carla Fedor, RN, CDDN Continuum of Care Project PSYCHOACTIVE MEDICATIONS Definition: Any medication which has the capability to alter mood, anxiety, behavior or

More information

Using the ASCP-NCOA Falls Risk Reduction Toolkit Part 1: A Companion to CDC's STEADI Toolkit

Using the ASCP-NCOA Falls Risk Reduction Toolkit Part 1: A Companion to CDC's STEADI Toolkit Using the ASCP-NCOA Falls Risk Reduction Toolkit Part 1: A Companion to CDC's STEADI Toolkit Target Audience: Pharmacists ACPE#: 0202-9999-18-056-L01-P Activity Type: Application-based Disclosures Kathleen

More information

Managing Nutrition and Unintended Weight Loss

Managing Nutrition and Unintended Weight Loss Managing Nutrition and Unintended Weight Loss Kathleen Niedert, PhD, RD, CSG, FADA, LNHA 2018 Spring Conference & Exhibitor Show May 2-3, 2018 OBJECTIVES Define the three main categories and three primary

More information

PRESCRIBING PRACTICE IN DELIRIUM. John Warburton Critical Care Pharmacist

PRESCRIBING PRACTICE IN DELIRIUM. John Warburton Critical Care Pharmacist PRESCRIBING PRACTICE IN DELIRIUM John Warburton Critical Care Pharmacist Learning outcomes Modifiable medication risk factors for delirium An appreciation of contributing factors modifiable with medicines

More information

Elavil (amitriptyline)

Elavil (amitriptyline) Generic name: Amitriptyline Available strengths: 10 mg, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg tablets; 10 mg/ml injection Available in generic: Yes Drug class: Tricyclic antidepressant General Information

More information

Preventing Falls in Older Adults A Matter of Safety

Preventing Falls in Older Adults A Matter of Safety Preventing Falls in Older Adults A Matter of Safety Roger Tam, BSc. Pharm. Wal-Mart Clinical Designated Pharmacist Falls Prevention Pharmacist Specialist NCCHC-Pre/Post Test Educator Q.U.I.T Educator Overview

More information

Nursing Process Focus: Patients Receiving Levodopa (Larodopa)

Nursing Process Focus: Patients Receiving Levodopa (Larodopa) Assessment Prior to administration: Obtain complete health history including allergies, drug history and possible drug interactions. Obtain baseline evaluation of severity of Parkinson s disease to determine

More information

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics. DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this

More information

PRESCRIBING IN THE ELDERLY. CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas

PRESCRIBING IN THE ELDERLY. CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas PRESCRIBING IN THE ELDERLY CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas LEARNING OUTCOMES Medicines Optimisation The effects of aging on health and medicines. Polypharmacy Acute Kidney

More information

Geriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center

Geriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center Geriatric Pharmacology Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center Silver Tsunami 2010: 40 million (13%) 2030: 72 million (20%) Baby Boomers (1946-1964)

More information

Medication Use in Older Adults

Medication Use in Older Adults Medication Use in Older Adults F. Michael Gloth, III, MD, AGSF, FACP, CMD Clinical Professor Department of Geriatrics, Florida State University College of Medicine Associate Professor of Medicine Division

More information

Residents Who Don t Sleep

Residents Who Don t Sleep Residents Who Don t Sleep Case study........................................... An 86 yr. old woman has diagnoses of Alzheimer s disease, congestive heart failure, constipation, depression, hypertension

More information

Medicine purposes and side effects

Medicine purposes and side effects Medicine purposes and side effects Ace inhibitors Purpose: Relaxes blood vessels and decreases blood volume, which lowers blood pressure and decreases oxygen demand from the heart Side effects: Low blood

More information

Chapter 01 Introduction

Chapter 01 Introduction Chapter 01 Introduction Defining the Elderly There is no universally accepted age cut-off defining elderly. This reflects the fact that chronological age itself is less important than biological events

More information

Prescribing Drugs to the Elderly

Prescribing Drugs to the Elderly Answers to your questions from University of Toronto experts Prescribing Drugs to the Elderly Can drugs do more harm than good? M.A. is a 90-year-old man living at home. He has dementia and due to wandering

More information

Tofranil and Tofranil-PM (imipramine)

Tofranil and Tofranil-PM (imipramine) Tofranil and Tofranil-PM (imipramine) Generic name: Imipramine Available strengths: 10 mg, 25 mg, 50 mg tablets; 75 mg, 100 mg, 125 mg, 150 mg capsules (Tofranil-PM) Available in generic: Yes Drug class:

More information

Patient Information VERSACLOZ (VER sa kloz) (clozapine) Oral Suspension

Patient Information VERSACLOZ (VER sa kloz) (clozapine) Oral Suspension Patient Information VERSACLOZ (VER sa kloz) (clozapine) Oral Suspension Read this Patient Information before you start taking VERSACLOZ and each time you get a refill. There may be new information. This

More information

IF I M NOT TREATING WITH OPIOIDS, THEN WHAT AM I SUPPOSED TO USE?

IF I M NOT TREATING WITH OPIOIDS, THEN WHAT AM I SUPPOSED TO USE? NON-OPIOID TREATMENT OPTIONS FOR CHRONIC PAIN Alison Knutson, PharmD, BCACP Medication Management Pharmacist Park Nicollet Creekside Clinic Dr. Knutson indicated no potential conflict of interest to this

More information

Strategies to manage medication related falls in older people

Strategies to manage medication related falls in older people Strategies to manage medication related falls in older people ALLEN R. HUANG, MDCM, FRCPC RGPEO Refresher Day, April 5, 2017 www.ottawahospital.on.ca Affiliated with Affilié à DISCLOSURES I have no conflict

More information

21 st June BDS BASHD Therapeutics Pain and Analgesia. BASHD Therapeutics Analgesics and Pain Management. Links to other BASHD content

21 st June BDS BASHD Therapeutics Pain and Analgesia. BASHD Therapeutics Analgesics and Pain Management. Links to other BASHD content Volume of Prescribing by Dentists 2011 ( a reminder) BASHD Therapeutics Analgesics and Pain Management Analgesics account for 1 in 80 dental prescriptions made A lot more analgesics will be suggested for

More information

Thank You to Our Sponsors: Evaluations & CE Credits. Featured Speakers. Conflict of Interest & Disclosure Statements 10/18/2016

Thank You to Our Sponsors: Evaluations & CE Credits. Featured Speakers. Conflict of Interest & Disclosure Statements 10/18/2016 Thank You to Our Sponsors: University at Albany School of Public Health NYS Department of Health Conflict of Interest & Disclosure Statements The planners and presenters do not have any financial arrangements

More information

Falls Prevention Best Practice

Falls Prevention Best Practice Falls Prevention Best Practice Prepared by Denise Tomassini Falls Prevention A case study : Mr Tony Topples ISLHD Clinical Quality Manager Clinical Governance Unit November 2011 Falls Prevention Best Practice

More information

Nursing Process Focus: Patients Receiving Chlorpromazine (Thorazine)

Nursing Process Focus: Patients Receiving Chlorpromazine (Thorazine) Nursing Process Focus: Patients Receiving Chlorpromazine (Thorazine) Potential Nursing Diagnoses Ineffective Therapeutic Regimen Management Risk for Activity Intolerance, related to side effect of drug

More information

Medications and ostomies. Sarah Drost, BSc Pharm, RPh, ACPR

Medications and ostomies. Sarah Drost, BSc Pharm, RPh, ACPR Medications and ostomies Sarah Drost, BSc Pharm, RPh, ACPR Overview 1. Medication absorption 2. Medication forms 1. Oral medications 2. Non-oral medication routes 3. Monitoring medications 4. Specific

More information

Delirium Assessment. February 24, Susan Schumacher, MS, APRN-BC

Delirium Assessment. February 24, Susan Schumacher, MS, APRN-BC Delirium Assessment February 24, 2016 Susan Schumacher, MS, APRN-BC Objectives Define delirium Differentiate delirium from dementia Identify predisposing and precipitating factors leading to delirium.

More information

Learning Objectives. Delirium. Delirium. Delirium. Terminal Restlessness 3/28/2016

Learning Objectives. Delirium. Delirium. Delirium. Terminal Restlessness 3/28/2016 Terminal Restlessness Dr. Christopher Churchill St. Cloud VA Health Care System EC&R Service Line Director & Medical Director Hospice & Palliative Care March 31, 2016 Learning Objectives Different Terminology

More information

Dr. Melissa Kagarise, PA C

Dr. Melissa Kagarise, PA C Dr. Melissa Kagarise, PA C This program has been supported by an educational grant from Pfizer Pharmaceuticals PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of

More information

Symbyax (Zyprexa [olanzapine] and Prozac [fluoxetine] combination)

Symbyax (Zyprexa [olanzapine] and Prozac [fluoxetine] combination) Symbyax (Zyprexa [olanzapine] and Prozac [fluoxetine] combination) Generic name: Olanzapine and fluoxetine combination Available strengths: 6 mg/25 mg, 6 mg/50 mg, 12 mg/25 mg, 12 mg/50 mg (Zyprexa/Prozac)

More information

Summary of Delirium Clinical Practice Guideline Recommendations Post Operative

Summary of Delirium Clinical Practice Guideline Recommendations Post Operative Summary of Delirium Clinical Practice Guideline Recommendations Post Operative Intensive Care Unit Clinical Practice Guideline for Postoperative Clinical Practice Guidelines for the Delirium in Older Adults;

More information

CARE HOME STAGE 2 - MULTIFACTORIAL FALLS RISK ASSESSMENT AND MANAGEMENT PLAN

CARE HOME STAGE 2 - MULTIFACTORIAL FALLS RISK ASSESSMENT AND MANAGEMENT PLAN CARE HOME STAGE 2 - MULTIFACTORIAL FALLS RISK ASSESSMENT AND MANAGEMENT PLAN FIRST NAME: DATE OF BIRTH: NHS NO: CARE HOME: ROOM NO: LAST NAME: Assessment to be completed on all residents aged 65 or older

More information

May 2015 Clinical Nurse Educator Arohanui Hospice

May 2015 Clinical Nurse Educator Arohanui Hospice May 2015 Clinical Nurse Educator Arohanui Hospice End of Life Care, what s on top? Feedback from last session (Physiology of Dying) Volunteer to present at August meeting Presentation: Breaking Bad News

More information

1/21/2016 UPDATE ON THE AMERICAN GERIATRICS SOCIETY 2015 BEERS CRITERIA DISCLOSURE OBJECTIVES AGING GOALS BEERS CRITERIA

1/21/2016 UPDATE ON THE AMERICAN GERIATRICS SOCIETY 2015 BEERS CRITERIA DISCLOSURE OBJECTIVES AGING GOALS BEERS CRITERIA UPDATE ON THE AMERICAN GERIATRICS SOCIETY 2015 BEERS CRITERIA DISCLOSURE I have no financial conflict of interest to disclose. Lacey Charbonneau, Pharm.D. PGY-1 Community Practice Resident Baptist Medical

More information

Multifactorial risk assessments and evidence-based interventions to address falls in primary care. Objectives. Importance

Multifactorial risk assessments and evidence-based interventions to address falls in primary care. Objectives. Importance Multifactorial risk assessments and evidence-based interventions to address falls in primary care Sarah Ross, DO, MS Assistant Professor Internal Medicine, Geriatrics Nicoleta Bugnariu, PT, PhD Associate

More information

A Step Forward: Promoting Independence through Falls Prevention

A Step Forward: Promoting Independence through Falls Prevention A Step Forward: Promoting Independence through Falls Prevention 2014 Geriatric Update Meharry Consortium Geriatric Education Center A Step Forward: Promoting Independence through Falls Prevention Moderator:

More information

DRUGS THAT ACT IN THE CNS

DRUGS THAT ACT IN THE CNS DRUGS THAT ACT IN THE CNS Anxiolytic and Hypnotic Drugs Dr Karamallah S. Mahmood PhD Clinical Pharmacology 1 OTHER ANXIOLYTIC AGENTS/ A. Antidepressants Many antidepressants are effective in the treatment

More information

Caring for a Patient or Family Member with Alzheimer s Disease or Related Dementia

Caring for a Patient or Family Member with Alzheimer s Disease or Related Dementia Caring for a Patient or Family Member with Alzheimer s Disease or Related Dementia Tiffany D. Long, MS4 UNC School of Medicine MD Candidate Class of 2018 Disclaimers A portion of this project is/was supported

More information

Pharmaceutical Care for Geriatrics

Pharmaceutical Care for Geriatrics Continuing Professional Pharmacy Development Program Pharmaceutical Care for Geriatrics Presented by: Alla El-Awaisi; MPharm, MRPharmS, MSc Event Organizer: Dr. Nadir Kheir; PhD Disclaimer: PRESENTING

More information

Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017

Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017 Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist HMS Training Webinar January 27, 2017 1 Describe nationwide prevalence and types of elderly dementia + define BPSD Define psychotropic

More information

Table to Demonstrate a method of working through Triggered CAPs.

Table to Demonstrate a method of working through Triggered CAPs. CAP Problem Goals Triggers Guidelines Physical Activities increase hours of exercises Reports less than 2 hours Personal choice Promotion and physical activity activity in last 3 days Instrumental Activities

More information

Can benadryl cause urinary retention

Can benadryl cause urinary retention Can benadryl cause urinary retention Gogamz Menu 27-9-2013 I would caution you that with chronic TEENney disease (CKD) that many patients are taking a multiple of medications and that each of these medications

More information

Letter from Home for Direct Care Providers Fall Risk Identification and Prevention

Letter from Home for Direct Care Providers Fall Risk Identification and Prevention Letter from Home for Direct Care Providers Fall Risk Identification and Prevention Each year, thousands of older adults will have a fall in their home. Falls are more common than strokes and can have just

More information

VI.2 Elements for a Public Summary

VI.2 Elements for a Public Summary VI.2 Elements for a Public Summary VI.2.1 Overview of disease epidemiology Zolpidem is used for short-term treatment of serious sleep problems that incapacitate or cause people extreme distress. Zolpidem

More information

High Risk Medication Management and the Elderly

High Risk Medication Management and the Elderly 1 High Risk Medication Management and the Elderly Lisa Uhlenkamp, RN, BA, LNHA Nurse Consultant Assisted Living Partners 2 As a person ages, gradual physiologic changes occur. Some of these age related

More information

Geriatric Pain Assessment and Management. Robin Arends, DNP, CNP, FNP-BC

Geriatric Pain Assessment and Management. Robin Arends, DNP, CNP, FNP-BC + Geriatric Pain Assessment and Management Robin Arends, DNP, CNP, FNP-BC + Objectives List three reasons why elderly are less likely to report pain. List three barriers to pain management Describe two

More information

FALLS PREVENTION. S H I R L E Y H U A N G, M S c, M D, F R C P C

FALLS PREVENTION. S H I R L E Y H U A N G, M S c, M D, F R C P C FALLS PREVENTION S H I R L E Y H U A N G, M S c, M D, F R C P C S T A F F G E R I A T R I C I A N T H E O T T A W A H O S P I T A L B R U Y E R E C O N T I N U I N G C A R E W I N C H E S T E R D I S T

More information

Health and Social Care Act 2008 (Regulated Activities) Regulations

Health and Social Care Act 2008 (Regulated Activities) Regulations Health and Social Care Act 2008 (Regulated Activities) Regulations 2014 12 Policy Statement The human body is essentially unstable; a vertical column on a narrow base. To be able to remain standing upright

More information

Michelle Zetoony, DO, FCCP, FACOI th Avenue S, Suite A Phone: Fax:

Michelle Zetoony, DO, FCCP, FACOI th Avenue S, Suite A Phone: Fax: Michelle Zetoony, DO, FCCP, FACOI 545 4 th Avenue S, Suite A Phone: 727-826-0933 Fax: 727-826-0744 http://www.dosleep.com SLEEP TALK 9/9 BMJ Open2012 Pharmacology and therapeutics Research What is sleep?

More information

Katee Kindler, PharmD, BCACP

Katee Kindler, PharmD, BCACP Speaker Introduction Katee Kindler, PharmD, BCACP Current Practice: Clinical Pharmacy Specialist Ambulatory Care, St. Vincent Indianapolis Assistant Professor of Pharmacy Practice, Manchester University,

More information

Formulary and Clinical Guideline Document Pharmacy Department Medicines Management Services

Formulary and Clinical Guideline Document Pharmacy Department Medicines Management Services Formulary and Clinical Guideline Document Pharmacy Department Medicines Management Services VIOLENCE, AGGRESSION OR SEVERE BEHAVIOURAL DISTURBANCE Introduction During an acute episode or illness, some

More information

A Geriatrician s Perspective on Successful Aging. Ariel Green, MD, MPH Assistant Professor of Medicine

A Geriatrician s Perspective on Successful Aging. Ariel Green, MD, MPH Assistant Professor of Medicine A Geriatrician s Perspective on Successful Aging Ariel Green, MD, MPH Assistant Professor of Medicine 1 Disclosures Johns Hopkins Clinical Research Scholars Program American College of Cardiology Foundation

More information

Practical Management of the Delirious Patient with Mental Retardation by the Nurse Anesthetist

Practical Management of the Delirious Patient with Mental Retardation by the Nurse Anesthetist Practical Management of the Delirious Patient with Mental Retardation by the Nurse Anesthetist 1. Basic Facts on Delirium The nurse anesthetist plays an important role in prevention of delirium among surgical

More information

What are you trying to achieve? Falls Prevention, Assessment and Management Strategies. Falls can be classified into four main groups:

What are you trying to achieve? Falls Prevention, Assessment and Management Strategies. Falls can be classified into four main groups: What are you trying to achieve? Falls Prevention, Assessment and Management Strategies Dr Adam Darowski Community: Falls risk assessment: Falls risk is 50% per year in 80yr population and higher in those

More information

ESSENTIAL CARE AFTER AN IN-PATIENT FALL

ESSENTIAL CARE AFTER AN IN-PATIENT FALL ESSENTIAL CARE AFTER AN IN-PATIENT FALL In line with the National Patient Safety Agency Rapid Response Report (NPSA/2011/RRR001): Essential care after an inpatient fall, in caring for a patient who has

More information

PRODUCT INFORMATION. Ammonium chloride is an expectorant that has an irritant effect on mucous membranes.

PRODUCT INFORMATION. Ammonium chloride is an expectorant that has an irritant effect on mucous membranes. PRODUCT INFORMATION BENADRYL Original Oral Liquid (New Formula) Name of the Medicine Diphenhydramine hydrochloride Ammonium chloride The chemical name for diphenhydramine hydrochloride is 2-(diphenylmethoxy)-N,Ndimethylethanamine

More information

Upper Extremity Fractures and Secondary Fall Prevention: Opportunities to Improve Management and Outcomes Across Disciplines

Upper Extremity Fractures and Secondary Fall Prevention: Opportunities to Improve Management and Outcomes Across Disciplines Upper Extremity Fractures and Secondary Fall Prevention: Opportunities to Improve Management and Outcomes Across Disciplines Christine McDonough, PhD, PT, CEEAA Health Outcomes Unit Department of Health

More information

Drugs for Emotional and Mood Disorders Chapter 16

Drugs for Emotional and Mood Disorders Chapter 16 Drugs for Emotional and Mood Disorders Chapter 16 NCLEX-RN Review Question 1 Choices Please note Question #1 at the end of Ch 16 pg 202 & Key pg 805 answer is #4 1. Psychomotor symptoms 2. Tachycardia,

More information

Objectives. 0 Identify medicines which increase the risk of falls and secondary injury on the farm/ranch.

Objectives. 0 Identify medicines which increase the risk of falls and secondary injury on the farm/ranch. Objectives 0 Identify medicines which increase the risk of falls and secondary injury on the farm/ranch. 0 Examine the impact of a medication assessment service on Missouri AgrAbility clients confidence

More information

Delirium, Depression and Dementia

Delirium, Depression and Dementia Delirium, Depression and Dementia Martha Watson, MS, APRN, GCNS Some material included in this presentation is adapted from: NICHE (2009). Geriatric Resource Nurse Core Curriculum [Power Point presentation].

More information

Pharmacology. Definitions. Pharmacology Definitions 8/20/2013. Drug:

Pharmacology. Definitions. Pharmacology Definitions 8/20/2013. Drug: Pharmacology Medications and their potential implications in physical therapy Definitions Drug: Any substance that alters physiologic function in the organism, regardless of whether the effect is beneficial

More information

Anxiety Pharmacology UNIVERSITY OF HAWAI I HILO PRE -NURSING PROGRAM

Anxiety Pharmacology UNIVERSITY OF HAWAI I HILO PRE -NURSING PROGRAM Anxiety Pharmacology UNIVERSITY OF HAWAI I HILO PRE NURSING PROGRAM NURS 203 GENERAL PHARMACOLOGY DANITA NARCISO PHARM D Learning Objectives Understand the normal processing of fear vs fear processing

More information

The Resident Who Screams

The Resident Who Screams The Resident Who Screams Case study........................................... A 72 year old female has diagnoses of dementia, optic nerve atrophy, irritable bowel syndrome and history of a TIA and DVT.

More information

Reduction of High Risk Medications Using A Quality Initiative Perspective

Reduction of High Risk Medications Using A Quality Initiative Perspective Reduction of High Risk Medications Using A Quality Initiative Perspective Richard Mueller PharmD, MBA, MS, Director of Pharmacy Dianne Hempel BSN, RN Quality Improvement Coordinator Objectives Learn what

More information

Chitra Fernando, MD March 18, 2008

Chitra Fernando, MD March 18, 2008 Chitra Fernando, MD March 18, 2008 Definition Statistics Risk factors Why older adults are more prone to ADE Manifestations Inappropriate medications for older adults What can be done to minimize adverse

More information

patient group direction

patient group direction DIAZEPAM v01 1/9 DIAZEPAM PGD Details Version 1.0 Legal category Staff grades Approved by CD Benz POM Paramedic (Non-ECP) Nurse (Non-ECP) Emergency Care Practitioner (Paramedic) Emergency Care Practitioner

More information

Medication Reviews within Care Homes. Catherine Armstrong

Medication Reviews within Care Homes. Catherine Armstrong Medication Reviews within Care Homes Catherine Armstrong What is a Medication Review? A structured, critical examination of a patient s medicines with the objective of reaching an agreement with the patient

More information

Pain CONCERN. Medicines for long-term pain. Antidepressants

Pain CONCERN. Medicines for long-term pain. Antidepressants Pain CONCERN Medicines for long-term pain Antidepressants Many people living with long-term pain (also known as chronic or persistent pain) are worried about using medicines like antidepressants. They

More information

Maximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016

Maximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016 Maximizing Medication Safety UNIVERSITY OF HAWAII AUGUST 31, 2016 Adverse Drug Events (ADE s) RISK FACTORS FOR Adverse Drug Events (ADEs) 6 or more concurrent chronic conditions 12 or more doses of drugs/day

More information

Fall Risk Assessment and Management. Elizabeth A. Phelan, MD, MS Assistant Professor, Medicine/Gerontology October 24, 2007

Fall Risk Assessment and Management. Elizabeth A. Phelan, MD, MS Assistant Professor, Medicine/Gerontology October 24, 2007 Fall Risk Assessment and Management Elizabeth A. Phelan, MD, MS Assistant Professor, Medicine/Gerontology October 24, 2007 Slide 2 OBJECTIVES Know and understand: The importance of falls by older persons

More information

Briefing Document on Medication use and Falls

Briefing Document on Medication use and Falls Briefing Document on Medication use and Falls This document is intended as a briefing document and is not to be regarded as a document offering definitive legal advice in relation to the subject matter.

More information

Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych

Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych A. Heterocyclic antidepressants: (tricyclic and tetracyclic ), e.g.amitryptaline,imipramine. B. Monoamine oxidase inhibitors(m.a.o.i), e.g.phenelzine.

More information

Why Target Delirium for Surgical Quality Improvement?

Why Target Delirium for Surgical Quality Improvement? Why Target Delirium for Surgical Quality Improvement? Tom Robinson MD FACS thomas.robinson@ucdenver.edu July 22, 2018 Disclosures Tom Robinson has no disclosures. Who Cares About the Brain? Acute Organ

More information

Care for patients with Neurological disorders

Care for patients with Neurological disorders King Saud University College of Nursing Medical Surgical Department Application of Adult Health Nursing Skills ( NUR 317 ) Care for patients with Neurological disorders Outline; EEG Overview. Nursing Interventions;

More information